mounjaro tirzepatide manufacturer eli lilly mounts clinical and commercial case for as Mounjaro, Zepbound chalk up major gains Eli Lilly gets nod to

PT-141 Regulatory Status As of June 2026, bremelanotide is FDA-approved as Vyleesi for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women

On Friday, the FDA responded in a court filing that compounding pharmacies could continue making the drug while the agency re-evaluates its finding, NBC News reported

A lot of the pain associated with a ligament tear is because of bleeding and swelling from the injury

Those experiencing stress, fatigue, or burnout

Bauer AZ, Kriebel D, Herbert MR, Bornehag CG, Swan SH

Quick Answer: Feeling cold on GLP-1 medications results from physiological changes during weight loss, including reduced insulating fat tissue, decreased caloric intake lowering heat production, and metabolic adaptations that make the body more energy-efficient